NCT03091894View on ClinicalTrials.gov

Dexmedetomidine Added to Propofol for Drug Induced Sleep Endoscopy

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 9, 2017

Primary Completion Date

April 8, 2018

Study Completion Date

April 8, 2018

Conditions
Obstructive Sleep Apnea of Adult
Interventions
DRUG

Propofol

propofol intravenous infusion via syringe pump with loading dose of 0.5 mg/kg over 3 minutes then continuous infusion in a dose of 25-75 ug/kg/minute

DRUG

Dexmedetomidine

dexmedetomidine intravenous infusion via syringe pump with loading dose of 0.5ug/kg over 5 minutes the continuous infusion in a dose of 0.2-0.7ug/kg/hour in addition to the propofol infusion as in propofol group

Trial Locations (1)

002055

Zagazig university, Zagazig

All Listed Sponsors
lead

Essam Fathi

OTHER_GOV

NCT03091894 - Dexmedetomidine Added to Propofol for Drug Induced Sleep Endoscopy | Biotech Hunter | Biotech Hunter